NWSA
88
10
NOC
35
-2
MU
54
8
VMC
48
10
R
70
7
AMGN
26
-4
MTCH
57
6
WBA
29
4
CHRW
64
2
NOV
53
-2
MUR
39
3
MNST
59
2
MAT
49
2
AON
75
-3
DE
63
5
EXPD
42
15
ALLE
35
3
BBY
56
4
LH
42
6
RSG
77
3
NWSA
88
10
NOC
35
-2
MU
54
8
VMC
48
10
R
70
7
AMGN
26
-4
MTCH
57
6
WBA
29
4
CHRW
64
2
NOV
53
-2
MUR
39
3
MNST
59
2
MAT
49
2
AON
75
-3
DE
63
5
EXPD
42
15
ALLE
35
3
BBY
56
4
LH
42
6
RSG
77
3
Financhill
Back

FibroGen Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
40

FGEN
FibroGen

Last Price:
$0.55
Seasonality Move:
-25.87%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
$64.86
Seasonality Move:
-1.74%
Sell
40
FibroGen (FGEN) is a Sell

Is FibroGen a Buy, Sell or Hold?

  • The current FibroGen [FGEN] share price is $0.55. The Score for FGEN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • FGEN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.85. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FGEN Stock Price Chart

What is FibroGen's stock price today?

  • The FibroGen share price today is $0.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGEN is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.85
    The current trend is relatively stagnant and BMRN is experiencing slight buying pressure.

FGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 58.52 Buy
Chaikin Money Flow: -16101 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.48 - 0.56) Buy
Bollinger Bands (100): (0.33 - 0.51) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 53.62 Buy
Chaikin Money Flow: 357106 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.89 - 65.05) Buy
Bollinger Bands (100): (63.61 - 68.99) Sell

FGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.5 Buy
20-day SMA: 0.5 Buy
50-day SMA: 0.49 Buy
200-day SMA: 0.64 Sell
8-day EMA: 0.51 Buy
20-day EMA: 0.51 Buy
50-day EMA: 0.49 Buy
200-day EMA: 0.91 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.33 Buy
20-day SMA: 63.28 Buy
50-day SMA: 64.87 Sell
200-day SMA: 74.82 Sell
8-day EMA: 64.3 Buy
20-day EMA: 64.03 Buy
50-day EMA: 64.96 Sell
200-day EMA: 73.2 Sell

FibroGen Earnings Growth & FGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.18 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.86 per share, and an increase next year of $0.97 per share.

FibroGen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):